Trailing-twelve-month (TTM) revenue is $7.21 Billion with a year-over-year growth of (2.17%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-11-01 | $1,594,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-20 |
| Q4 FY2025Period ended 2026-01-31 | $2,724,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-12 |
| Q1 FY2026Period ended 2026-05-02 | $1,378,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-27 |
| Q2 FY2026Period ended 2026-08-01 | $1,514,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-26 |
| TTM revenue | $7,210,000,000 |
Current P/S: $3,237,082,701 market capitalization ÷ $7,210,000,000 TTM revenue = 0.45x.
Market capitalization source: FMP quote. Quote observed 2026-10-02T20:00:02.000Z. Latest revenue period ended 2026-08-01.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-08-01): $1.51B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-02T20:30:36.710Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-01.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2021-01-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-02-01 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20152016-01-30 · USD | FY20162017-01-28 · USD | FY20172018-02-03 · USD | FY20182019-02-02 · USD | FY20192020-02-01 · USD | FY20202021-01-30 · USD |
|---|---|---|---|---|---|---|
| Bath & Body Works | $3.6B | $3.9B | $4.1B | $4.6B | $5.2B | $6.4B |
| Other Operating Segments | $510M | $518M | $595M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20122013-02-02 · USDDisclosure unavailable | FY20202021-01-30 · USD | FY20212022-01-29 · USD | FY20222023-01-28 · USD | FY20232024-02-03 · USD | FY20242025-02-01 · USD |
|---|---|---|---|---|---|---|
| Bath & Body Works International | N/A | $224M | $283M | $339M | $340M | $299M |
$7.21B
$7.21 Billion
(2.17%)
vs. $7.37B a year ago (TTM)
(5.75%)
5 Year compound annual growth rate
1 Year
(2.17%)
3 Year
(1.07%)
5 Year
(5.75%)
10 Year
(5.26%)
15 Year
(2.23%)
20 Year
(1.60%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $7.29B | ($16.00M) | (0.22%) |
| 2024 | $7.31B | ($122.00M) | (1.64%) |
| 2023 | $7.43B | ($131.00M) | (1.73%) |
| 2022 | $7.56B | ($322.00M) | (4.09%) |
| 2021 | $7.88B | +$1.45B | +22.51% |
| 2020 |
TTM Growth
(2.17%)
3-Year CAGR
(1.07%)
5-Year CAGR
(5.75%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-02T20:30:36.710Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-01.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $339M |
| N/A |
| Victoria's Secret | $8.1B | $8.2B | $7.4B | $7.4B | $6.8B | $5.4B |
|---|
| $6.43B |
| +$1.03B |
| +19.04% |
| 2019 | $5.41B | ($7.83B) | (59.17%) |
| 2018 | $13.24B | +$605.00M | +4.79% |
| 2017 | $12.63B | +$58.00M | +0.46% |
| 2016 | $12.57B | +$420.00M | +3.46% |
